Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BioChain to Distribute Clinical Genomics' Cancer Test in China

publication date: Oct 31, 2014
BioChain, a diagnostics company with operations in San Francisco and China, has become the exclusive China distributor of Clinical Genomics' colorectal cancer screening technology. Clinical Genomics of Australia has marketed Insure FIT®, a fecal immunochemical test, around the globe since 1994. BioChain, which will run a China trial of the test to qualify for CFDA approval, will attempt to make the test part of China's recently announced Cancer Screening Feasibility Study. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital